NCT04687709View on ClinicalTrials.gov

To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

December 6, 2022

Study Completion Date

September 26, 2023

Conditions

Prostate Cancer

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT04687709 - To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients | Biotech Hunter | Biotech Hunter